Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

[Active surveillance for prostate cancer].

M Graefen¹, S Ahyai, R Heuer

¹Martini-Klinik, Prostatazentrum an der Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany. graefen@uke.uni-hamburg.de

Der Urologe. Ausg. A

|February 15, 2008

Summary

This summary is machine-generated.

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of peritoneal bladder flap in robot-assisted radical prostatectomy patients on lymphoceles: a prospective randomised trial.

World journal of urology·2025

Same author

Skin manifestations of hypereosinophilic syndrome are polymorphous and difficult to treat: A retrospective cohort study.

Annales de dermatologie et de venereologie·2022

Same author

Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome.

The British journal of dermatology·2021

Same author

[Quality criteria in urology : How to obtain comparable results?]

Der Urologe. Ausg. A·2021

Same author

Vesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapy.

World journal of urology·2020

Same author

Synthetic Elastography Using B-Mode Ultrasound Through a Deep Fully Convolutional Neural Network.

IEEE transactions on ultrasonics, ferroelectrics, and frequency control·2020

Active surveillance offers favorable survival for low-risk prostate cancer patients, especially older men or those with comorbidities. However, psychological burden can lead to early protocol exit and potential undertreatment.

Area of Science:

Urology
Oncology

Context:

Active surveillance is a key strategy for managing newly diagnosed low-risk prostate cancer.
Watchful waiting demonstrates favorable cancer-specific survival rates in select patient groups.
Definitive therapy is beneficial when life expectancy exceeds 10-15 years.

Purpose:

To evaluate the role and challenges of active surveillance in low-risk prostate cancer management.
To highlight the importance of precise identification of insignificant prostate cancers.
To discuss criteria for initiating definitive therapy within active surveillance protocols.

Summary:

Active surveillance involves regular PSA measurements and follow-up biopsies, though protocols lack standardization.
Histological progression and PSA elevation are primary indicators for treatment initiation.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Experiment Videos

Last Updated: Jul 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

A minority of eligible patients currently utilize active surveillance, with many discontinuing early due to psychological distress.

Impact:

Active surveillance may lead to undertreatment if progression is not accurately monitored.
Psychological burden associated with untreated cancer significantly impacts patient adherence to surveillance.
Further research is needed to optimize active surveillance protocols and patient support.